HARBIN, China, Sept. 1 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky One Medical" or "the Company") (Nasdaq: CSKI), a leading fully integrated pharmaceutical company producing over-the-counter drugs in the People's Republic of China ("PRC"), today announced the Company will present at the upcoming Rodman & Renshaw Annual Global Investment Conference to be held on September 9-11 at the New York Palace Hotel in New York City. The Company will also conduct a non-deal roadshow in the U.S. during the week of September 14.
The Rodman & Renshaw Annual Global Investment Conference is a three-day event which features tracks devoted to Healthcare, Metals & Mining, Energy, Clean-tech, Asia, Community & Regional Banks, Growth, & Maritime. So far, more than 500 companies have registered to attend the conference. Schedule of China Sky One Medical's presentation is as follows:
Date: Thursday, September 10th, 2009 Time: 10:25 a.m. Eastern Time Venue: Louis Salon (4th Floor) New York Palace Hotel 455 Madison Avenue, NY 10022
During the conference, the Company will be available for one-on-one meetings. For more information about the conference, please visit http://www.rodm.com/conferences .
To complement its participation at the conference, China Sky One Medical is also scheduled to launch a non-deal roadshow in the U.S. from September 14-18. Mr. Yan-qing Liu, Chairman and CEO of the Company, and Mr. Stanley Hao, the CFO of China Sky One Medical, will meet with securities analysts and investors in Boston, Chicago, Denver, San Francisco and Los Angeles.
"We are excited to participate in the upcoming conference and conduct a non-deal roadshow in the U.S.," commented Mr. Yan-qing Liu, Chairman and CEO of China Sky One Medical. "This is a unique opportunity for us to present China Sky One Medical's story to meet the investment community and provide an update on our business plan and growth strategy. We value effective and direct communication with our shareholders and potential investors."
The non-deal roadshow is being hosted by CCG Investor Relations. A copy of the presentation to be used for the conference and the roadshow will be posted on the Company's website at http://www.cski.com.cn on or before September 10, 2009.
About China Sky One Medical, Inc.
China Sky One Medical, Inc., a Nevada corporation, is a holding company. The Company engages in the manufacturing, marketing and distribution of pharmaceutical, medicinal and diagnostic products. Through its wholly-owned subsidiaries, Harbin Tian Di Ren Medical Science and Technology Company ("TDR"), Harbin First Bio- Engineering Company Limited ("First"), Heilongjiang Tianlong Pharmaceutical, Inc. ("Tianlong") and Peng Lai Jin Chuang Pharmaceutical Company ("Jin Chuang") the Company manufactures and distributes over-the-counter pharmaceutical products, which make up its major revenue source. For more information, visit http://www.cski.com.cn .
Safe Harbor Statement
Certain of the statements made in the press release constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements can be identified by the use of forward- looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology. Such statements typically involve risks and uncertainties and may include financial projections or information regarding the attendance of investment conferences and non-deal road show meetings. Actual results could differ materially from the expectations reflected in such forward-looking statements as a result of a variety of factors, including the risks associated with the effect of changing economic conditions in The People's Republic of China, variations in cash flow, reliance on collaborative retail partners and on new product development, variations in new product development, risks associated with rapid technological change, and the potential of introduced or undetected flaws and defects in products, and other risk factors detailed in reports filed with the Securities and Exchange Commission from time to time.
For more information, please contact: Company Contact: China Sky One Medical, Inc. Mr. Stanley Hao, CFO Tel: +86-0451-5399-4069 Email: email@example.com Investor Relations Contact: CCG Investor Relations Mr. Crocker Coulson, President Tel: +1-646-213-1915 Email: firstname.lastname@example.org Web: http://www.ccgirasia.com
|SOURCE China Sky One Medical, Inc.|
Copyright©2009 PR Newswire.
All rights reserved